You are here

Article info

Article menu
Download PDFPDF
Original Article
Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer

Authors

  • Sarah E Taylor Division of Gynecologic Oncology, Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Jennifer S Petschauer Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Heidi Donovan School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Allison Schorzman Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Juan Razo Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • William C Zamboni Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA PubMed articlesGoogle scholar articles
  • Robert P Edwards Division of Gynecologic Oncology, Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Kristin K Zorn University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Sarah E Taylor, Division of Gynecologic Oncology, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA; taylorse2{at}mail.magee.edu
View Full Text

Citation

Taylor SE, Petschauer JS, Donovan H, et al
Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer
International Journal of Gynecologic Cancer 2019;29:147-152.

Publication history

  • Received October 19, 2018
  • Revision received October 16, 2018
  • Accepted July 9, 2018
  • First published January 7, 2019.
Online issue publication 
May 15, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.